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Introduction: Beside positive effects on athlete’s health, competitive sport can be
linked with an increased risk of illness and injury. Because of high relative increases
in training, additional physical and psychological strains, and an earlier specialization
and professionalization, adolescent athletes needs an increased attention. Training can
alter the immune system by inducing a temporary immunosuppression, finally developing
infection symptoms. Previous studies identified Epstein Barr Virus (EBV) as potential
indicator for the immune status. In addition to the identification of triggering risk factors
for recurrent infections, the aim was to determine the interaction between training load,
stress sense, immunological parameters, and clinical symptoms.
Methods: A controlled, prospective, longitudinal study on young athletes (n = 274,
mean age: 13.8 ± 1.5 yrs) was conducted between 2010 and 2014. Also 285 controls
(students, who did not perform competitive sports, mean age: 14.5 ± 1.9 yrs) were
recruited. Athletes were examined 3 times each year to determine the effects of stress
factors (training load: training hours per week [Th/w]) on selected outcome parameters
(clinical [susceptibility to infection, WURSS-21: 21-item Wisconsin Upper Respiratory
Symptom Survey], immunological, psychological end points). As part of each visit, EBV
serostatus and EBV-specific IgG tiers were studied longitudinally as potential immune
markers.
Results: Athletes (A) trained 14.9 ± 5.6 h weekly. Controls (C) showed no lower stress
levels compared to athletes (p = 0.387). Twelve percent of athletes reported recurrent
infections (C: 8.5%, p = 0.153), the presence of an upper respiratory tract infection
(URTI) was achieved in 30.7%. EBV seroprevalence of athletes was 60.3% (C: 56.6%,
p = 0.339). Mean EBV-specific IgG titer of athletes was 166 ± 115 U/ml (C: 137 ± 112
U/ml, p = 0.030). With increasing Th/w, higher stress levels were observed (p < 0.001).
Analyzes of WURSS-21 data revealed no relationship to training load (p = 0.323). Also,
training load had no relation to EBV serostatus (p = 0.057) or the level of EBV-specific
IgG titers (p = 0.364).
Discussion: Young elite athletes showed no increased sense of stress, no higher
prevalence of recurrent infections, and no different EBV-specific serological parameters
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compared to controls. Also, no direct relationship between training loads, clinical
complaints, and EBV-specific immune responses was found. With increasing training
loads athletes felt more stressed, but significant associations to EBV-specific serological
parameters were absent. In summary, EBV serostatus and EBV-specific IgG titers do not
allow risk stratification for impaired health. Further investigations are needed to identify
additional risk factors and immune markers, with the aim to avoid inappropriate strains
by early detection and following intervention.
Keywords: EBV, URTI, athlete, training load, infection, susceptibility, stress, immune system
INTRODUCTION
Competitive sport is associated with various physical and
psychological strains (Sabato et al., 2016; Schwellnus et al.,
2016a,b). Beside positive effects on athlete’s health andwell-being,
including cardiovascular and muscular fitness, bone health,
weight control, psychosocial outcomes, cognitive and brain
health, and reducedmorbidity and premature death (Wartburton
and Bredin, 2016, 2017; Chieffi et al., 2017), acute prolonged
exercise can be linked with an increased risk of illness and injury
(Armstrong and Mc Manus, 2011; Hastmann-Walsh and Caine,
2015). Success requires numerous years of training, starting
already in adolescence, with presumed health and less lack of
practice to achieve sports specific skills and necessary overall
capacity (Mårtensson et al., 2014). The trend of recent years
shows an increased duration, intensity, and difficulty of training,
a high-frequency participation in sports events, and an earlier
specialization and professionalization (Mountjoy et al., 2008;
Caine, 2010; Armstrong and Mc Manus, 2011). Such conditions
can negatively affect the risk of physical and psychological illness
and injury (Armstrong and Mc Manus, 2011; Sabato et al.,
2016). Therefore, to ensure resilience in young athletes, age-
based additional endo- and exogenous risk factors, which can
negatively influence the ability to withstand stress, should be
known and considered: e.g., physical development, high training
load (DiFiori and Mandelbaum, 1996; Dennis et al., 2005;
Dun et al., 2005; Loud et al., 2005; Fleisig et al., 2011; Hjelm
et al., 2012), early specialization (Barynina and Vaitsekhovskii,
1992; Bompa, 1995; Jayanthi et al., 2013), performance capacity,
previous illnesses, environmental factors, and negative stressors
such as school, parental conflicts, pressure to perform, and
competition failure (Cohn, 1990; Scanlan et al., 1991; Puffer and
McShane, 1992; Gould et al., 1993; Puente-Diaz and Anshel,
2005). Ignoring the multifactorial interactions of various triggers
can lead to a diminished immune competence affecting health,
training and ability for regeneration (Borresen and Lambert,
2009; Dhabhar, 2014). Light clinical symptoms over one episode
usually result in short training breaks. In contrast, recurrent
infections, mild or severe, can cause frequent interruptions,
lack or stagnation of performance, retirement from competitive
sports, furthermore, influencing long-term everyday life (Maffulli
et al., 2010; Whittaker et al., 2015).
Upper respiratory tract infections (URTI) belong to the
most common diseases in athletes (Gleeson and Pyne, 2016;
Schwellnus et al., 2016a). Beside musculoskeletal injuries
(Schwellnus et al., 2016b), they are the main cause responsible
for training failures, suboptimal performances, and competition
cancellations (Fricker, 1997; Alonso et al., 2010; Engebretsen
et al., 2010, 2013; Mountjoy et al., 2010; Schwellnus et al., 2011,
2016a; Soligard et al., 2014). During the Winter Olympics 2014
in Sotschi, 8.9% of athletes had an illness, 64% of them an
URTI as reason (Soligard et al., 2014). While the prevalence
of URTI is comparable to the general population, an increased
rate of susceptibility was found in athletes (Gleeson et al.,
1995; Fricker et al., 2000). Studies have shown that moderate
exercise reduces the incidence of infections compared to physical
inactivity (Matthews et al., 2002). In contrast, high-intensity or
rather extensive training loads are associated with an increased
susceptibility to infections due to a diminished transient immune
competence (Peters and Bateman, 1983; Fricker et al., 1999;
Gleeson et al., 2000; Spence et al., 2007). The duration of
this mentioned immunosuppression takes several hours, called
as >open window< (Walsh and Oliver, 2016). Training,
particularly high intensities, and marked load increases, can
induce this temporary immunosuppression causing recurrent
infections (Gleeson et al., 2000; Konig et al., 2000; Tiollier
et al., 2005; Tsai et al., 2011; Walsh et al., 2011a; Hellard et al.,
2015). Nevertheless, other potentially triggers and promotive risk
factors must also be considered, such as previous illnesses (e.g.,
bronchial asthma; Reid et al., 2004; Spence et al., 2007; Cox et al.,
2008), female gender (Himmelstein et al., 1998; Konig et al., 2000;
He et al., 2014), age (Monto, 2002), genetic predispositions (Cox
et al., 2010; Zehsaz et al., 2014), low IgA secretion rates (Gleeson
et al., 1995, 1999; Putlur et al., 2004; Fahlman and Engels,
2005; Nieman et al., 2006), air travel (Svendsen et al., 2016),
cold (Walsh and Oliver, 2016), heat (Walsh and Oliver, 2016),
hypoxia (Walsh and Oliver, 2016), stress (Novas et al., 2002;
Putlur et al., 2004; Main et al., 2010), lack of sleep (Cohen et al.,
2009; Main et al., 2010), malnutrition (Zapico et al., 2007; Walsh
et al., 2011b; Calder et al., 2014), and weight loss (Umeda et al.,
2004; Shimizu et al., 2011). So far, it remains still controversial
which factors, degree (e.g., duration, intensity, frequency), and
attendant circumstances must be present for affecting immune
system and finally developing clinical complaints (Fricker et al.,
2000; Konig et al., 2000).
In addition to the question which factors lead to an
impaired health and performance, it is necessary to quantify
immunological parameters that potentially indicate a risk
early. The clinical relevance of such immunological changes
remains controversial. So far, no direct association between
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immune responses and increased infection rates could be clearly
demonstrated (Reid et al., 2004; Fricker et al., 2005; Helenius
et al., 2005; Tiollier et al., 2005; Cox et al., 2008). Consistently,
physical stress activates the immune system more or less,
depending on amount, intensity and frequency, resulting in
weakness or stabilization. An association between low saliva
IgA concentrations or rather reduced secretion rates and
URTI symptoms has been demonstrated (Gleeson et al., 1995,
1999; Putlur et al., 2004; Fahlman and Engels, 2005; Nieman
et al., 2006). Nevertheless, the results are inconsistent and the
quantitation requires complex and time-consuming demands
(Gleeson, 2000; Walsh et al., 2011a). A limitation that makes
it difficult to use in practice. Therefore, simple, non-invasive
and feasible tools should be developed including parameters that
influence and reflect the immunological aspect of the individual
capacity and resilience.
Diminished performance and fatigue with concurrent
unspecific flu-like symptoms are often associated with an Epstein
Barr Virus (EBV) infection in competitive athletes (Gleeson
et al., 2002; Balfour et al., 2015). This herpes virus persists
lifelong in the organism and is controlled by the adaptive
immune system. The detection of antibodies to specific EBV
antigens by immunoblot allows to determine the infection stage
(De Paschale and Clerici, 2012). In contrast to other viruses
(e.g., varicella-zoster virus, cytomegalovirus), replication of
EBV occurs frequently by reactivation, intermittently or even
continuously. Thus, in addition to EBV-specific antibodies, the
viral genome is also well accessible for polymerase chain reaction
(PCR, viral load), allowing the detection of a systemically
increased EBV activity in whole blood or saliva (Yamauchi et al.,
2011). The lifelong persistence in the organism after primary
infection and a prevalence of more than 90% in adults, and
between 55 and 80% in adolescent (Karrer and Nadal, 2014;
Lee, 2016), make EBV-specific immune responses suitable as
interesting surrogate markers for the immune function of the
host (Karrer and Nadal, 2014).
EBV and accordingly the immunological reactions to the virus
can be used as indicator of the current immune status (Gleeson
et al., 2002; Pottgiesser et al., 2012). Thus, EBV and accordingly
the immunological reactions to the virus could help to identify
athletes with an increased susceptibility to infections (Bakker
et al., 2007; Hoffmann et al., 2010). Despite immunological
changes, obvious clinical symptoms, and further potential
impairments of performance, do not necessarily occur. Lower
EBV-specific IgG titers were detected in winter sports athletes
compared to controls suggesting a weaker immune function
in competitive athletes with lower control of EBV (Hoffmann
et al., 2010), in addition, observed slightly elevated EBV-specific
IgG titers over the competition season were interpreted as a
reaction to increased EBV activity accompanying stress-induced
diminished T-cell function (Hoffmann et al., 2010). However,
similar results from other studies were missed (He et al., 2013).
Furthermore, there has been an ongoing controversy whether
EBV infections among elite athletes occur at a higher incidence
than in the general population (Pottgiesser et al., 2006). Thus, the
clinical relevance of EBV infections remains unclear, especially in
competitive sports, because a clear relationship between training,
EBV-specific parameters, clinical symptoms and performance
could not be demonstrated consistently.
The challenge is to objectify individual resilience in order
to control future burdens and thus to be able to counteract
overloading at all levels. With a proven relationship, the training
could be adjusted to prevent clinical complaints. First of all, it
is necessary to identify a dependent cascade between physical,
psychological, and environmental stress factors, their effects on
immunological parameters and their association to performance
and clinical symptoms. So far, only isolated aspects have been
examined with different results (Fricker et al., 1999, 2005;
Gleeson et al., 2000; Konig et al., 2000; Reid et al., 2004; Pyne et al.,
2005; Walsh et al., 2011a,b; Hellard et al., 2015). Furthermore,
past studies weremostly undertaken on heterogeneous collectives
with a small number of cases and selection of inconsistent
outcomes (Cox et al., 2008; Alonso et al., 2010; Mountjoy et al.,
2010; Dvorak et al., 2011; Schwellnus et al., 2012; Theron et al.,
2013).
To date, the relationship between stress parameters, immune
status and clinical outcomes, and the characterization of each
aspect, have not been sufficiently addressed, especially in young
elite athletes. Due to this lack, a prospective study was initiated,
in which selected parameters in detail and their relationships
to each other were examined. The study involved young elite
athletes who were monitored longitudinal and included a
clinical assessment for known causes of impaired health and
performance, the determination of immune reactions and a
standardized collection of illness parameters. The following
hypotheses should be investigated: (1) Due to the high training
loads, already at a young age, the athletes show a higher
susceptibility to infections and prevalence of URTI, and indicate
an increased sense of stress compared to controls; (2) EBV-
specific immune responses can be used as a potential biomarker
of the overall immune status due to the high EBV seroprevalence
in adolescence; (3) Differences in EBV-specific IgG titers will be
detected in the young athlete collective compared to controls;
(4) High training loads lead to an impaired stress sense and
increase the incidence of clinical complaints; (5) Training load
and stress affect the immune system; (6) The prevalence of
upper respiratory tract infections (URTI) is associated with EBV
serostatus and EBV-specific IgG titers.
Comprehensive data were collected to characterize the
collective of young elite athletes. For the present analysis the
following parameters were selected: training hours per week
(training load), self-reported stress level, EBV serostatus and
EBV-specific IgG titers (immune status), upper respiratory tract




A controlled, prospective, longitudinal study was conducted
between 2010 and 2014 with several regenerations, training
and competitive seasons. Each year, the athletes were examined
three times to determine the effects of certain stress factors
(e.g., training load), plus their dynamics, on selected outcome
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measures (e.g., clinical, immunological, psychological end
points). The study design included up to 13 visits per athlete.
The timeline for the prospective surveillance study is shown
in Figure 1. Comprehensive parameters for characterization of
each athlete were determined once a year at one of three sports
medicine centers (Munich, Leipzig,Dresden) to detect underlying
conditions including case history, physical examination,
anthropometry, clinical chemistry, ECG (electrocardiogram),
echocardiography, and stress test. Additional baseline data and
contained questionnaires that assessed e.g., training history,
training loads, the WURSS-21 (21-item Wisconsin Upper
Respiratory Symptom Survey), and health-related demands
(self-reported health/stress sense, fatigue) were collected. As part
of each visit, EBV serostatus and EBV-specific IgG titers were
determined longitudinally.
Participants
The athletes were recruited from different sport disciplines.
Participation in the examinations (Munich, Leipzig or Dresden)
was required. A total of 274 national class adolescent athletes
(national junior top-level or comparable training level, age:
13.8 ± 1.5 years [yrs], male [m]: n = 175, female [f]: n = 99)
from ten different sports (cross-country skiing [n = 43], cycling
[n = 64], figure skating [n = 6], gymnastics [n = 4], high
diving [n = 6], soccer [n = 72], speed skating [n = 11],
swimming [n = 30], tennis [n = 7], volleyball [n = 31])
were enrolled in the study. The sports were categorized into
three groups depending on the dynamic load (low: gymnastics,
high diving; medium: figure skating, volleyball; high: speed
skating, cycling, swimming, cross-country skiing, soccer, tennis;
Mitchell and Haskell, 2005). The athletes were located in 18
training groups at seven locations. Prior to commencement
of the investigations each athlete underwent a comprehensive
clinical examination and was checked to assess inclusion (at
V1 age ≤18 years; competing successfully at international or
national level competitions for at least 2 years; belonging to
one of the 18 training groups to ensure systematic training;
future perspective of the athlete; written informed consent from
parents and athletes) and exclusion criteria (chronic pathology
or use of drugs that affected immune function; long-lasting
injury or illness at V1). Athletes were prospectively followed for
2.2 ± 1.1 yrs. The maximum time between initial examination
(V1) and the last visit (mean age: 16.1 ± 1.9 yrs) was 4
years. In addition, 285 control subjects (students, who did not
perform competitive sports, age: 14.5 ± 1.9 yrs, m: n = 122,
f: n = 163) were recruited. Athletes were tested up to ten
times while controls had a maximum of two tests. In both
groups, not all subjects could be tested at each time points
resulting in some missing values. In total, 2.600 study days
(athletes: 2.259, controls: 341) were collected. Depending on
the analysis, data with inadequate detail in the recording were
excluded. All athletes and controls were fully informed about the
rationale for the study and of all procedures to be undertaken.
Before baseline visit (V1) participants and their parents signed
a written informed consent form. The study was approved
by the medical research ethics committee (TU München) and
it conforms to the principles outlined in the Declaration of
Helsinki.
Outcome and End Point Definitions
EBV Serology
Blood samples were collected at each visit and peripheral blood
was taken by puncture of the antecubital vein. EBV-specific
IgG and IgM antibodies were measured by ELISA (Enzygnost R©,
Siemens Healthcare Diagnostics GmbH, Germany) according
to the manufacturer’s instructions. The assay detects antibodies
directed against early EBV antigens (EA), viral capsid EBV
antigens (VCA), and EBV nuclear antigen 1 (EBNA-1) in
equal proportions. EBV-specific IgG and IgM antibodies were
reported in units per milliliter (U/ml). The lower limit of
detection was 25 U/ml. RecomLine R© EBV IgG immunoblot
assay (Mikrogen GmbH, Germany) detects antibodies against
various EBV antigens (EBNA-1 [p72]), VCA [p18 and p23]),
immediate-early antigen (BZLF-1), and EA [p138 and p54]).
EBV-specific antibodies present in the cohort sample bound to
these recombinant antigens and were detected by secondary
antibodies directed against human IgG and coupled with
horseradish peroxidase. Band signals were evaluated and stages
of EBV infection (EBV serostatus) were differentiated according
to the manufacturer’s instructions in the following categories:
FIGURE 1 | Timeline for the prospective study.
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EBV-seronegative (EBV–), EBV-seropositive (EBV+), suspicion
of EBV reactivation (sRA), and suspected EBV infection (sNI).
Upper Respiratory Tract Infection (URTI)
The WURSS-21 (21-item Wisconsin Upper Respiratory Symptom
Survey) was used to compute symptoms of URTI (Barrett et al.,
2005). This questionnaire is a responsive, reliable and valid
instrument including 21 items (10 items: symptoms, 9 items:
functional impairments, 1 item: global severity and global change
over the last 24 h). All the items are responded to using a Likert
scale of severity, ranging from 0 to 7. Symptoms not experienced
were recorded as 0. An overall score (WTS) was calculated
by adding the severity scores from the items 2–20 with high
severity scores indicating high symptom load. An URTI episode
was deemed present when total symptom score was greater
seven, representing either one severe symptom or impairment
or seven mild symptoms/impairments presented simultaneously.
The occurrence of URTI symptoms were recorded at each visit
every third day in an observation period of 2 weeks (5 times per
visit). For representing the whole time span, all available scores
were averaged.
Self-Reported Stress Level, Susceptibility to
Infection, Training Load
Each subject was asked to complete a questionnaire prior each
examination among (1) stress level (%), (2) susceptibility to
infection, and (3) training load (Th/w).
(1) To estimate the individual level of stress a visual analog
scale (VAS) was used, with a range from 0 to 100 percent. A
higher score indicated greater stress sense (0: “no stress,” 100:
“highest stress level”). (2) In addition, athletes were asked if
they felt sick more often (compared to the past/to others). The
question could be answered with “yes”, “no”, “I don’t know.” If the
question was answered with “yes,” there was a subjective tendency
to recurrent infections (susceptibility to infection). (3) For every
visit, training loads were recorded after completing questionnaire
and interview. In addition, the average number of training hours
per week (Th/w) of the last 4 weeks was reported.
Statistical Analyses
The data were compiled using Microsoft Excel R© and evaluated
using the SPSS R© software (version 23.0; SPSS Lead Technologies
Inc, Chicago, IL). Frequency distributions of all continuous
variables were examined to detect outlying values, and the
Kolmogorov-Smirnov test was used to check the normal
distribution of variables. All results, assuming normal
distribution, were presented as mean ± standard deviation
(SD). Differences between groups were analyzed using an
independent samples t-test. To determine the differences in
the group analysis (e.g., WURSS-21), ANOVA was used. The
chi-square test was performed to verify possible differences
between nominal scaled variables. Significance was accepted
at the P < 0.05 level. Depending on the analysis, data were
stratified by sex and age, were presented by percentiles (using
10th and 90th percentile), and variables were categorized in
ordinal gradation.
RESULTS
Characterization (Training Load, Stress
Level, Susceptibility to Infection, URTI) and
Comparison of the Collectives (Athletes vs.
Controls)
Training Load
During the study period, the athletes (age: 15.1± 1.9 yrs) trained,
on average, 14.9 ± 5.6 h weekly (>80% specific training for each
sports discipline). Increasing training loads were significantly
associated with a higher age (<10 h: 13.6 ± 1.8 yrs vs. ≥10 h:
15.4 ± 1.7 yrs, p < 0.001). A 16-year-old female figure skater
achieved the maximum of 31.5 h. 22.3% of all, in particular
40.2% of the female athletes (m: 11.6%), completed at least
20 h of training per week, mostly belonging to gymnastics
(25.9 ± 1.9 h), high diving (23.5 ± 4.6 h), or figure skating
(22.8 ± 4.9 h). Remarkable, athletes of these three kind of sports
were significantly younger compared to the others (13.7± 1.8 yrs
vs. 15.2 ± 1.8 yrs, p = 0.002). Female volleyball players offered,
despite younger age (f: 14.9 ± 1.5 yrs vs. m: 16.1 ± 1.0 yrs,
p = 0.008), higher training loads compared to the male team (f:
20.4 h vs. m: 11.7 h, p < 0.001).
Stress Level
Taking all athletes’ data sets into account, a mean stress level
of 45.3 ± 18.0% (MIN 0%, MAX 88.0%) was reported. Unlike
the male participants, female athletes felt more stressed (f:
50.0± 15.7% vs. m: 42.5± 18.6%, p= 0.001). Similar results were
found in the control group (f: 50.8± 25.9 % vs. m: 41.4± 23.9%,
p= 0.005), who had in comparison to the athletes no lower stress
levels (47.0 ± 25.5%, p = 0.387), in both sexes (f: p = 0.789, m:
p= 0.668). The control subjects indicated amaximum stress level
of 90.0%.
Susceptibility to Infection
At baseline visit 12.0% of competitive athletes (A) reported a
subjective susceptibility to infection with no significant difference
compared to the control (C) group (A: 12.0% vs. C: 8.5%,
p= 0.153), in female (A: 18.2% vs. C: 12.3%, p= 0.188) as well as
in male subjects (A: 8.6% vs. C: 3.3%, p= 0.064). Female athletes
and female controls reported more often recurrent infections
than males (A: f: 18.2% vs. m: 8.6%, p = 0.019; C: f: 12.3% vs.
m: 3.3%, p = 0.006). Exemplary, no male volleyball player was
anamnestic susceptible to infections, compared to 33.3% of the
female players. While 11-year-old athletes had a prevalence of
7.7% for recurrent infections, this increased to 13.0% at the age
of 14, and to 44% among 17-year-old participants (Figure 2).
Athletes with recurrent infections (I+) were older compared to
clinically unremarkable (I−) subjects (I−: 13.7 ± 1.5 yrs vs. I+:
14.4± 1.6 yrs, p= 0.016). During the total study process, while an
observation period of 2.2± 1.1 yrs, 32.8% of all athletes reported
recurrent illnesses, again with a significantly higher occurrence in
the female group (f: 51.5% vs. m: 22.3%, p < 0.001).
URTI
The mean total WURSS-21 score (WTS) was 6.98 ± 10.25, with
a highest value of 62.40. Gender differences did not occur (f:
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FIGURE 2 | Prevalence of susceptibility to infection in athletes depending on age. Values are expressed as means.
7.28± 10.39 vs. m: 6.67± 10.12, p= 0.430). A total score greater
seven (WTS > 7 at least in one of five surveys within one visit),
and thus the presence of an URTI, was achieved in 30.7% of
cases (f: 30%, m: 31.5%). Among these, the gender proportion
was similar (f: 48.4%, m: 51.6 %, p= 0.674). No age dependencies
could be shown, neither of WTS (p = 0.829), nor in terms of
URTI prevalence (p= 0.957).
EBV Serostatus
At V1, 60.3% of the athletes (mean age: 13.8 ± 1.5 yrs)
were EBV-seropositive, including 6.1% of the athletes with
a serological suspected EBV reactivation (sRA), and 0.6%
with a primary EBV infection (sNI). The proportion of EBV-
seropositive subjects did not differ significantly between male
and female athletes (m: 58.6% vs. f: 63.3%, p = 0.452). Male
subjects were significantly younger (m: 13.6 ± 1.5 yrs vs. f:
14.0± 1.6 yrs, p= 0.041), but no significant differences regarding
the percentage of EBV-seropositive female and male athletes
were detected. Furthermore, EBV-seropositive (EBV+) athletes
showed a similar age compared to EBV-seronegative (EBV–
) subjects (EBV+: 13.8 ± 1.6 yrs vs. EBV–: 13.6 ± 1.4 yrs,
p = 0.351), both in male (p = 0.166) and female participants
(p = 0.695). 56.6% of the controls (mean age: 14.5 ± 1.9 yrs)
were EBV-seropositive, resulting in no significant differences
of the EBV serostatus compared to the athletes at baseline
visit (p = 0.376). In line with the athlete group, no significant
gender difference was observed within the control group (EBV+:
m: 53.7% vs. f: 58.8%, p = 0.339). Age-depending analyzes
between the athlete and control group revealed comparable
numbers of EBV-seropositive subjects (e.g., age 13 yrs: A
(n = 54): 42.6% vs. C (n = 36): 44.4%, p = 0.862; age 14
yrs: A (n = 77): 67.5 % vs. C (n = 64): 62.5%, p = 0.532;
age 15 yrs: A (n = 54): 63% vs. C (n = 52): 61.5%,
p= 0.880).
EBV-Specific Antibody Levels
In 145 athletes (m: n = 91, f: n = 54; age: 13.8 ± 1.6 yrs) EBV-
specific IgG-titers (mean 166 ± 115 U/ml; range 30–810 U/ml)
were detectable at baseline visit (V1). Female athletes showed
significantly higher EBV-specific IgG titers compared to male
athletes (f: 197 ± 145 U/ml vs. m: 147 ± 89 U/ml, p = 0.012), an
age dependency was not proven (p= 0.365). Endurance athletes
(high dynamic kind of sports) had the lowest EBV-specific IgG
titers, compared to athletes of low and medium dynamic kind
of sports (high: 153 ± 104 U/ml vs. medium: 225 ± 148 U/ml
vs. low: 189 ± 138 U/ml, p = 0.025). The mean detectable EBV-
specific IgG titers of the control group were 137 ± 112 U/ml
(range: 26–878U/ml), resulting in significant lower levels of EBV-
specific IgG titers compared to the athletes at V1 (p= 0.030). This
difference was confirmed in sub-analyzes of the male subjects
(p = 0.026), but not in females (p = 0.055) (Figure 3). Similar
to the athlete group, female control subjects showed higher EBV-
specific IgG titers (C: m: 113 ± 90 U/ml vs. f: 152 ± 122 U/ml,
p = 0.038), without any apparent age dependency (p = 0.839).
The highest detectable EBV-specific IgG titer wasmeasured in the
collectives of the control subjects (C: 878 U/ml vs. A: 810 U/ml).
It Was Investigated Whether the Subjective
Stress Level, an Increased Susceptibility to
Infections, and the Occurrence of URTI Are
Related to the Extent of Training Loads
Training Load∼Stress Level
With increasing training loads, defined as hours per week (Th/w),
according to ordinal categorization (6 groups), a higher stress
level was observed (<5 h: 42.2± 26.1%, 5 –≤9.9 h: 41.8± 25.7%,
10 –≤14.9 h: 47.2± 24.3%, 15 –≤19.9 h: 52.9± 21.9%, 20–≤24.9
h: 54.4± 23.6%,≥25 h: 61.4± 17.9%, p < 0.001), both in female
(p= 0.007) and male athletes (p= 0.029). The 90th percentile of
training load was 20 h per week, the 10th percentile was 6 h per
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FIGURE 3 | EBV-specific IgG-titers (U/ml) in comparison between athletes and controls. (A) male subjects. (B) female subjects. #p < 0.05. *Extreme value (defined
as a value that is smaller (or larger) than 3 box-lengths).
week. Significant differences in stress sensation were identified
between the three groups (≤6 h: 40%, >6–<20 h: 48.3%, ≥20 h:
55.6%, p< 0.001). This counted for both sexes, female (p= 0.007)
and male athletes (p= 0.029).
Training Load∼Susceptibility to Infection
Based on the ordinal categorization, athletes with less than 5 h
training load per week (Th/w) showed the highest prevalence
of susceptibility to infections (20%). Overall, no significant
differences between the groups were observed (<5 h: 20%, 5–
≤9.9 h: 11.4%, 10–≤14.9 h: 11.1%, 15–≤19.9 h: 13.4%, 20–≤24.9
h: 12.8%,≥25 h: 11.5%, p= 0.436), in both sexes (f: p= 0.113, m:
p = 0.843). Athletes with a training load of at least 20 h per week
(90th percentile), reported not more often recurrent infections
compared to athletes with less strains (≤6 h: 13%, >6–<20 h:
12.4%, ≥20 h: 12.6%, p= 0.982).
Training Load∼URTI
Analyzes of WURSS-21 data revealed no ordinal relationships
between training loads and WTS (<5 h: 8.74 ± 13.42, 5–≤9.9 h:
6.60 ± 9.16, 10–≤14.9 h: 7.36 ± 11.52, 15–≤19.9 h: 4.92 ± 7.21,
20–≤24.9 h: 6.21 ± 9.33, ≥25 h: 13.74 ± 16.81, p = 0.016),
or rather URTI prevalence (<5 h: 30.8%, 5–≤9.9 h: 29.9%, 10–
≤14.9 h: 30.8%, 15–≤19.9 h: 22.4%, 20–≤24.9 h: 31.3%, ≥25
h: 46.7%, p = 0.323). But, an obvious higher score (WTS) and
URTI prevalence were seen at trainings loads of at least 25 Th/w.
Taking into account the categorization according to percentiles,
significant associations were also missing (URTI: ≤6 h: 25.8%,
>6–<20 h: 28.2%, ≥20 h: 34.2%, p = 0.479), both, in female
(p= 0.702) and male group (p= 0.146).
In Order to Show a Possible Influence of
Training and Stress on the Immune
System, Training Hours per Week and
Subjective Stress Levels Were Compared
With EBV-Specific Parameters
Training Load∼EBV Serology
Training loads (Th/w) had no relation to EBV-serostatus (EBV–:
12.3 ± 5.3 h vs. EBV+: 13.0 ± 5.7 h, p = 0.057). After ordinal
categorization of the training load (six groups), the relating
mean EBV-specific IgG-titers were determined. No significant
correlations between training hours per week and the extent of
EBV-specific IgG-titers was observed (<5 h: 111 ± 75 U/ml, 5–
≤9.9 h: 138 ± 99 U/ml, 10–≤14.9 h: 146 ± 110 U/ml, 15–≤19.9
h: 149± 113 U/ml, 20–≤24.9 h: 148± 113 U/ml,≥25 h: 127± 45
U/ml, p = 0.364). Sub-analyzes of different training loads in
female (p = 0.791), and male athletes (p = 0.380) revealed
no gender-specific significant differences. Also after comparing
the EBV-specific IgG-titers between the percentile groups, no
significant differences were recognizable (≤6 h: 144 ± 104
U/ml, >6–<20 h: 147 ± 109 U/ml, ≥20 h: 117 ± 80 U/ml,
p= 0.087). However, subgroup analyzes illustrated obvious lower
EBV-specific IgG titers for athletes who trained at least 20 h per
week (≥20 h: 117 ± 80 U/ml vs. >6–<20 h: 147 ± 109 U/ml,
p = 0.028; ≥20 h; 117 ± 80 U/ml vs. ≤6 h: 144 ± 104 U/ml,
p= 0.072).
Stress Level∼EBV Serology
EBV-seropositive athletes reported significantly higher
stress levels compared to EBV-seronegative subjects (EBV–:
44.8 ± 24.4% vs. EBV+: 49.1 ± 25.0%, p = 0.004). This
difference was confirmed in female athletes (p = 0.002), but not
in the male collective (p = 0.393). After subdividing the subjects
in different age groups, no significant differences regarding the
stress level of EBV-seronegative and EBV-seropositive athletes
were observed. Exemplary, in the subgroup of 18-year-old
subjects, EBV-seronegative athletes showed stress levels of
54.0 ± 5.5%, in contrast to 46.1 ± 22.9% of EBV-seropositive
athletes (p = 0.450). After further serological differentiation,
athletes with suspected EBV reactivation (sRA) or primary EBV
infection (sNI) offered the highest levels of stress sense (EBV–:
44.8 ± 24.4%, EBV+: 48.5 ± 24.9%, sRA: 58.8 ± 24.0%, sNI:
57.1 ± 25.8%, p = 0.004). Based on ordinal categorization of the
stress levels (five groups), relative EBV-specific IgG-titer were
assessed and compared with each other. Differences between
the groups were not found, neither in the overall cohort (≤10%:
129 ± 83 U/ml, >10–≤30%: 128 ± 83 U/ml, >30–≤50%:
143± 106 U/ml, >50–≤70%: 150± 117 U/ml, >70%: 142± 127
U/ml, p = 0.279), nor in the female (p = 0.303) or male
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group (p = 0.186). Analyzes based on the percentiles yielded
comparable results (≤10%: 129± 83 U/ml, >10–80%: 141± 105
U/ml, ≥80%: 143± 133 U/ml, p < 0.601).
Finally, the Relations Between
EBV-Specific Parameters and Clinical
Outcomes Were Investigated
EBV Serology∼Susceptibility to Infection
12.4% of EBV-seronegative and 11.8% of EBV-seropositive
athletes reported recurrent infections. The difference was
not significant, both in female (p = 0.178) and male sub-
collectives (p = 0.575). Exemplary, 25.0% of EBV-seronegative
athletes above 18 years declared susceptibility to infections, in
contrast to 16.7% of EBV-seropositive subjects (p = 0.681).
Closer examination of clinically conspicuous athletes showed a
prevalence rate of 63.7% compared to a prevalence rate of 64.9%
in healthy athletes (p = 0.769). These results were confirmed
regardless of age- and gender-based sub-analyzes. Athletes with
recurrent infections had no significant different levels of EBV-
specific IgG-titers compared to clinically healthy subjects (I–:
139 ± 102 U/ml vs. I+: 160 ± 120 U/ml, p = 0.078), in both
genders (f: I–: 151± 121 U/ml vs. I+: 179± 135 U/ml, p= 0.118;
m: I–: 129 ± 84 U/ml vs. I+: 120 ± 63 U/ml, p = 0.580). The
highest rates of susceptibility to infections were found in athletes
within the 90th percentile group of EBV-specific IgG-titers, but
with no significance (≤51 U/ml: 9.6% vs.>51–<268 U/ml: 10.3%
vs. >268 U/ml: 15.3%, p= 0.415).
EBV Serology∼URTI
There was no relation between EBV serostatus and extent of
WTS (EBV–: 6.59 ± 9.40 vs. EBV+: 7.14 ± 10.48, p = 0.470),
in both genders (f: p = 0.128, m: p = 0.529). Also, the URTI
prevalence (WTS >7) between the two groups did not differ
(EBV–: 31.6% vs. EBV+: 30.2%, p = 0.486). This was confirmed
in all age ranges (≤12 yrs: EBV–: 28.6% vs. EBV+: 31.8%,
p = 0.791; 13–14 yrs: EBV–: 31.5% vs. EBV+: 28.8%, p = 0.661;
15–16 yrs: EBV–: 33.3% vs. EBV+: 31.7%, p = 0.773; 17–18
yrs: EBV–: 28.0% vs. EBV+: 26.3 %, p = 0.874; >18 yrs: EBV–
: 100% vs. EBV+: 36.4%, p = 0.460). 62.8% of the athletes
with reported URTI symptoms were EBV seropositive, 64.3% of
athletes without an URTI (p = 0.696). Athletes with serological
suspected EBV reactivation showed the highest WTS, but no
significant difference in comparison to the other groups was
found (EBV–: 6.56± 9.40, EBV+: 7.09± 10.57, sRA: 9.45± 8.70,
sNI: 5.84 ± 8.07, p = 0.641; Figure 4). The same was shown for
the URTI prevalence (EBV–: 31.6%, EBV+: 29.6%, sRA: 52.6%,
sNI: 30.0%, p = 0.183). Subjects with conspicuous WTS (>7)
did not differ in EBV-specific IgG-titers from the unremarkable
participants (URTI–: 137 ± 101 U/ml vs. URTI+: 158 ± 114
U/ml, p = 0.082), neither in female (URTI–: 164 ± 122 U/ml
vs. URTI+: 170 ± 127 U/ml, p = 0.393) nor in male subjects
(URTI–: 121 ± 74 U/ml vs. URTI+: 143 ± 95 U/ml, p = 0.100).
In further analyzes, the URTI prevalence was determined as a
function of the percentiles. An ordinal increase in prevalence
with higher EBV-specific IgG-titers was evident, but at no time
with any significance (URTI:≤51 U/ml: 17.9%,>51–<268 U/ml:
29.9%, ≥268 U/ml: 43.2%, p= 0.064l; Figure 5).
In addition, presentation of the results was made in tabular
form (Tables 1–3).
DISCUSSION
The major aim of the study was to determine the interaction
between training load, stress level, immune status, and clinical
FIGURE 4 | URTI prevalence and WURSS-21 total score (WTS) depending on EBV serostatus (EBV–: EBV-seronegative [n = 253], EBV+: EBV-seropositive
[n = 392], sRA: suspected reactivation [n = 19], sNI: suspected new infection [n = 5]). Values are expressed as means.
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FIGURE 5 | URTI prevalence and WURSS-21 total score (WTS) depending on EBV-specific IgG titers categorized in different percentiles (≤10th percentile: ≤51 U/ml,
>10th-<90th: >51-<268 U/ml, ≥90th: ≥268 U/ml). Values are expressed as means.
TABLE 1 | Clinical parameters of EBV-seronegative and -seropositive athletes.
EBV-seronegative EBV-seropositive P
Age (yrs) 13.6 ± 1.4 13.8 ± 1.6 = 0.351
Stress level (%) 44.8 ± 24.4 49.1 ± 25.0 = 0.004*
Training load (Th/w) 12.3 ± 5.3 13.0 ± 5.7 = 0.057
Recurrent Infections (%) 12.4 11.8 = 0.769
WTS 6.59 ± 9.40 7.14 ± 10.48 = 0.470
URTI prevalence (%) 31.6 30.2 = 0.696
WTS, WURSS-21 total score; URTI; Upper respiratory tract infection. Data are shown as
mean ± SD and percentage values. *p < 0.01.
endpoints. In advance, an independent evaluation of each
parameter, with the relationships to each other, were necessary to
characterize the cohort of young elite athletes. Therefore, a large
prospective study was initiated involving young elite athletes
who were monitored longitudinally in terms of clinical relevant
parameters.
On the way becoming a top athlete, many barriers are to
overcome. Success needs a high degree of health, because less
lack of practice for exercising the physiological demands is
necessary (Armstrong and Mc Manus, 2011; Hastmann-Walsh
and Caine, 2015). In particular, adolescence needs an increased
attention (Sabato et al., 2016). First, because of the high relative
increase in training in this timeframe, on the other hand due
to the consideration of additional factors influencing individual
development, such as school, parental conflicts, puberty, or other
physical and psychological strains (Cohn, 1990; Scanlan et al.,
1991; Puffer and McShane, 1992; Gould et al., 1993; Puente-
Diaz and Anshel, 2005). For the athlete, a safe passage through
this phase with presumed health and continuous training must
be ensured (Mårtensson et al., 2014). Therefore, knowledge
of necessary conditions, at all levels (e.g., clinical, physical,
psychological), are essential (Sabato et al., 2016). Although junior
sports have become more and more the focus of science and
public in recent years, large prospective studies characterizing
young athletes in this regard are missing (Armstrong and Mc
Manus, 2011). The knowledge of all influencing factors, including
their weighting, makes it possible to regulate them in order to
avoid negative consequences.
High-performance sport is associated with physical strains. To
ensure an optimal development, systematic increases in training
loads, from adolescence to adulthood, are necessary to avoid
overtraining or negative health outcomes (Sabato et al., 2016).
In certain kind of sports, high levels of training are mandatory
even at a young age (Armstrong and Mc Manus, 2011). On the
one hand, e.g., gymnastics need physical requirements, which
are limited in adulthood, on the other hand, e.g., tennis players
have to learn difficult skills already in the early age. So it is not
uncommon from an age of 12–13 years to train 15–20 h per
week (Armstrong andMcManus, 2011). Our study examined 274
junior athletes from ten different sports. Already at a mean age
of 15 years, the average training load was nearly 15 h per week,
with amaximum of over 30 h. One in five athletes (22.3%) trained
at least 20 h a week. There were marked differences in training
loads between the athletes, depending on age, gender, kind of
sports, and localization. The results illustrated that young athletes
offer high training loads, comparable to adults. In addition to
the training, also school lessons are to complete resulting in over
60 h overall strain per week. Despite the same sport, age, and
gender, the strains can vary clearly and, therefore, have to be
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TABLE 2 | Clinical and immune parameters dependent on training load (training hours per week).
Training load (Th/w) Stress level (%) Recurrent infections (%) WTS URTI (%) EBV-specific IgG (U/ml)
<5 42.2 ± 26.1 20 8.74 ± 13.42 30.8 111 ± 75
5 – ≤9.9 41.8 ± 25.7 11.4 6.60 ± 9.16 29.9 138 ± 99
10 – ≤14.9 47.2 ± 24.3 11.1 7.36 ± 11.52 30.8 146 ± 110
15 – ≤19.9 52.9 ± 21.9 13.4 4.92 ± 7.21 22.4 149 ± 113
20 – ≤24.9 54.4 ± 23.6 12.8 6.21 ± 9.33 31.3 148 ± 113
≥25.0 61.4 ± 17.9 11.5 13.74 ± 16.81 46.7 127 ± 45
< 0.001** = 0.436 = 0.016# = 0.323 = 0.364
WTS, WURSS-21 total score; URTI, Upper respiratory tract infection. Data are shown as mean ± SD and percentage values. #p < 0.05, **p < 0.001.
TABLE 3 | Clinical parameters and training loads dependent on EBV-specific IgG titers categorized in different percentiles (≤10th percentile: ≤51 U/ml, >10th-<90th:
>51-<268 U/ml, ≥90th: ≥268 U/ml).
EBV-specific IgG (U/ml)
≤10th percentile >10th-<90th percentile ≥90th percentile p
Stress level (%) 52.8 ± 24.1 47.6 ± 25.1 52.0 ± 23.7 = 0.093
Training load (Th/w) 12.2 ± 5.5 13.1 ± 5.8 13.2 ± 5.2 = 0.429
Recurrent Infections (%) 9.6 10.3 15.3 = 0.415
WTS 5.31 ± 11.60 6.84 ± 9.94 9.94 ± 12.25 = 0.117
URTI prevalence (%) 17.9 29.9 43.2 = 0.064
WTS, WURSS-21 total score; URTI, Upper respiratory tract infection. Data are shown as mean ± SD and percentage values.
evaluated individually. Since young athletes show similar training
loads as top-level adults, an adequate infrastructure (e.g., medical
network) should already be available as early as possible.
Training can alter the immune system, by inducing a
temporary immunosuppression (Reid et al., 2004; Fricker et al.,
2005; Helenius et al., 2005; Tiollier et al., 2005; Cox et al., 2008),
finally developing clinical complaints (Fricker et al., 2000; Konig
et al., 2000). Competitive sport is associated with an increased
risk for illness and injury (Armstrong and Mc Manus, 2011;
Hastmann-Walsh and Caine, 2015). Here, upper respiratory tract
infections belong to the most common reasons for impaired
health and a diminished ability for regeneration (Schwellnus
et al., 2016a). In certain circumstances, recurrent infections
can result in frequent interruptions, lack of performance,
and possibly retirement from competitive sports, furthermore,
influencing long-term everyday life (Fricker, 1997; Alonso et al.,
2010; Engebretsen et al., 2010, 2013; Mountjoy et al., 2010;
Schwellnus et al., 2011, 2016a; Soligard et al., 2014). Based on the
temporary immunosuppression, we assumed, that athletes show
a higher susceptibility to infections, an increased prevalence of
URTI, due to the high training loads already at a young age,
and indicate an impaired sense of stress compared to controls
(hypothesis 1). To prove these assumptions and to characterize
each young elite athlete concerning this matter, following
parameters were systematically examined and evaluated: (a)
subjective stress level, (b) susceptibility to infections, (c) upper
respiratory tract infection symptoms.
(a) Stress can negatively affect health (Novas et al., 2002;
Putlur et al., 2004; Main et al., 2010). Therefore, the general aim
is to minimize stress factors. In competitive sports, high training
loads are inevitable, which can increase the subjective sense of
stress and, thus, adversely affect the athletes’ health. The cascade
between extent of training, stress level, and health, respectively
performance, is still unclear. Remarkable, our analyzes showed
no increased sense of stress among the athletes compared to
the control group, despite higher training loads and therefore
increased strains. This illustrates the individual and multi-
factorial etiology of stress. The counteracting positive effects of
exercise on stress level can be assumed (e.g., increased vagotonus,
structured everyday life, social environment, recognition, mental
stability). In accordance to the literature, female subjects, in
both cohorts, showed higher stress levels. In further analyzes,
athletes with increased subjective stress levels have to been
selected. After determining them, triggering risk factors can
be avoided. Further investigations are needed to identify such
triggering stress factors for developing appropriate interventions
(Schwellnus et al., 2016a).
(b) Studies found an increased rate of recurrent infections
in athletes due to a diminished transient immune competence
after high-intensity or rather extensive training loads (Peters and
Bateman, 1983; Fricker et al., 1999; Gleeson et al., 2000; Spence
et al., 2007). In contrast, moderate exercise reduces the incidence
of infections compared to physical inactivity (Matthews et al.,
2002). This relation between extent of exercise and infection
prevalence is described as J-shaped curve. To each visit, athletes
and controls were asked how frequent they felt sick. At baseline
visit a susceptibility to infections affirmed twelve percent of the
athletes. There was no significant difference to the controls,
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maybe justified by the young age, fewer years of training, and,
therefore, less chronic effects on the immune system. However,
a gender difference was detected with a higher prevalence of
subjective recurrent infections in female subjects, both in athletes
and controls. Recent studies have shown fewer episodes of
infections in successful top-ranking athletes, mentioned as S-
curve relationship (Mårtensson et al., 2014; Hellard et al., 2015).
In the future, the question must be clarified whether a certain
adaptation of the immune system is responsible for this, the
results are based on a selection mechanism, or the outcome
is compatible with a better lifestyle (Schwellnus et al., 2016a).
It must be noted, that our results are based on self-reported
data. The clinical relevance of such subjective susceptibility to
infection remains to be investigated. An increased physical focus
of the athlete compared to the general population is conceivable.
However, in our analyzes no higher prevalence of recurrent
infections between both collectives was found.
(c) In addition to the subjective susceptibility to infections,
the WURSS-21 was used to compute symptoms of URTI as an
objective and validated clinical endpoint (Barrett et al., 2005).
After calculation of the WURSS-21 total scores (WTS), no
differences depending on age and sex were observed. Overall, a
maximum value of 133 could have been achieved. In contrast,
during analyzed observation a mean WURSS-21 score of under
seven was found, leading to the assumption of an investigated
collective with less clinical complaints. Fewer chronical effects
of long-lasting and intensive training loads on immune system
are feasible reasons for the results. On the other hand, there
might be a different perception of exercise in adolescence
(e.g., less pressure to succeed, “playful” component), with the
used questionnaire symptoms and functional impairments were
recorded. Furthermore, the objectivization of influencing the
performance in practice remains questionable and needs more
investigation.
The persistence of EBV in the organism after primary
infection, the lifetime prevalence of more than 90%, the simple
measurement of infection stage after an antigen-antibody-
reaction, the practicable detection of a systemically increased
EBV activity in whole blood or saliva, and the known associations
to clinical parameters, although with inconsistent results, make
EBV and accordingly the immunological reactions to the virus as
interesting markers of the overall immune function of the host
(Gleeson et al., 2002; Pottgiesser et al., 2012; Karrer and Nadal,
2014). In our own preliminary work, we examined EBV-specific
serological parameters in adult elite athletes (Pottgiesser et al.,
2006, 2012; Hoffmann et al., 2010). To clarify the use of EBV-
specific immune responses as a potential marker of the immune
status (hypothesis 2), we investigated the EBV seroprevalence in
our recruited adolescent subjects. The examined athletes showed,
at a mean age of approximately 14 years, an EBV seroprevalence
of already 60%. Serostatus differences did not depend on sex
and age. Particularly, in controls a similar prevalence rate
was found (56.6%). The missing difference confirmed previous
data (Pottgiesser et al., 2006; Hoffmann et al., 2010). So, the
incidence of primary infection, and thus seroconversion, does
not depend on the level of physical training, and argue against an
increased EBV seroprevalence in athletes (Hoffmann et al., 2010).
The elicited EBV prevalence corresponds with the literature
(Pottgiesser et al., 2012). Because of the already high rate of
seroprevalence in adolescence, EBV-specific parameters can be
used as potential immune markers for further analyzes.
Illness, impaired performance, and fatigue are often associated
with EBV infection (Balfour et al., 2015). High-intensity or
rather extensive training loads transiently diminish the immune
competence (Peters and Bateman, 1983; Fricker et al., 1999;
Gleeson et al., 2000; Spence et al., 2007). Encouraging this
assumption, lower EBV-specific IgG tiers were detected in studies
with competitive athletes compared to controls (Hoffmann et al.,
2010). In this regard, the authors suggested a weaker immune
function in competitive athletes. Therefore, we assumed lower
EBV-specific IgG titers in young elite athletes compared to
controls (hypothesis 3). However, we measured higher antibody
titers in the samples of young athletes. These data suppose a
necessary chronic influence of training loads on immune system
for obvious alterations, e.g., lower antibody titers. Otherwise,
the elevated EBV-specific IgG titers are a result of a reaction to
increased EBV activity accompanying stress-induced diminished
T-cell function (Hoffmann et al., 2010). So, a reduced T-cell
function allows higher EBV loads, and in turn stimulating IgG
production. To prove the effects, an additional determination
of viral loads (EBV DNA) and EBV-specific T-cell responses, in
a longitudinal study design, and the consideration of different
seasonal time points are necessary. These was done in the present
study. However, we refer to future publications regarding these
results. Sub-analyzes proved the lowest IgG titers in endurance
athletes in comparison to subjects of sports with a medium or
low dynamic load. Possibly, the missing IgG titer differences to
controls are due the high activity of the students in this age range.
In summary, our results showed no differences in EBV serostatus
and no lower EBV-specific IgG titers in athletes compared to
controls in adolescent age.
Consistent data on the relationship between physical,
psychological, and environmental stress factors, their effects on
immunological parameters and their association to performance
and clinical symptoms are missing. After analyzing parameters
(training load, subjective stress level, EBV seroprevalence,
EBV-specific IgG titers, susceptibility to infections, and upper
respiratory tract infection symptoms) for themselves, the
associations to each other have been addressed.
At first, we inspected if high training loads lead to an impaired
stress sense and increase the incidence of clinical complaints
(hypothesis 4). With increasing training loads, athletes felt
more stressed, both in female and male athletes. The results
were expected and can be justified with the higher time effort
of training sessions. Contrariwise, controls showed no lower
subjective stress levels compared to athletes despite more leisure
time. Athletes offered an average training load of nearly 15 h per
week corresponding with a mean stress level under 50 percent.
In contrast, athletes with at least 25 h per week reported a level
above 60%. So, a cut-off value of hours per week is to be assumed.
The missing difference to the controls illustrated moreover
the necessary consideration of further triggering factors, which
cause conspicuous stress sense. Consequently, the positive and
negative aspects of competitive sports should always be taken
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into account. In addition to the presence of high strains, the
individual handling of these should also be assessed. For further
sub-analyzes athletes with high stress levels but low training
loads will be selected. In addition, the influences of the extent
of training load on infection-related parameters were examined.
Neither the occurrence of subjective susceptibility to infection
nor the presence of relevant clinical symptoms (URTI) were
affected by the amount of exercise. Athletes with training loads
of at least 25 h per week showed an obvious higher rate of an
URTI (46.7%). However, an ordinal gradation of occurrence did
not depend on training load. It is important to mention, that
athletes with training loads under 5 h per week were mostly ill,
resulting in high prevalences of clinical parameters in this group.
In summary, no direct relationship between training loads and
clinical outcomes were found. In further analyzes, ill and injured
athletes should be excluded.
Published studies documented an altered immune system
depending on strains (Dennis et al., 2005; Dun et al., 2005;
Fleisig et al., 2011). We assumed an influence of training
loads and stress sense on the immune system, hence, on EBV-
specific parameters (hypothesis 5). In the examined young athlete
collective, significant associations between training loads or
rather stress levels and EBV-specific serological parameters, as
potential immune markers, were absent. In our preliminary
work we found lower EBV-specific IgG titers in competitive
athletes compared to controls (Hoffmann et al., 2010). This
could reflect weaker immune function because of high training
loads. In the present study, EBV-specific IgG levels from young
athletes do not correlate to training loads and subjective stress
levels. Unique, athletes with a suspected EBV reactivation showed
significantly higher stress levels compared to the others. For an
adequate evaluation, further multivariate subgroup analyzes with
the addition of other relevant parameters (e.g., EBV DNA, CRP,
leucocytes) will be achieved.
Clinical relevant symptoms, such as recurrent infections and
fatigue, are often associated with EBV (Balfour et al., 2015).
So, studies with competitive athletes showed an association
between viral load and the frequency of respiratory infections
(Gleeson et al., 2002). Based on that, we assumed a relationship
between the prevalence of upper respiratory tract infections
(URTI) and EBV-serostatus or rather EBV-specific IgG titers.
In the conducted analyzes, neither the prevalence of upper
respiratory tract infections (WTS > 7) nor the occurrence of
susceptibility to infections are associated with EBV-serostatus
or EBV-specific IgG titer levels. High IgG titers tended to
show conspicuous clinical complaints, but at no time with
a significance. Particularly, athletes with serological suspected
EBV reactivation (sRA) presented the highest prevalence for
URTI, even if there was no significant difference between the
groups.
In summary, young elite athletes offered high training loads
comparable to adults. Athletes showed no increased sense
of stress, no higher prevalence of recurrent infections, and
no different EBV-specific serological parameters compared to
controls. With increasing training loads athletes felt more
stressed, but significant associations to EBV-specific serological
parameters were absent. Also no direct relationships between
training loads and clinical outcomes with EBV-specific immune
responses were found.
Due to the high strain variability, each athlete has to be
evaluated individually, taking into account all influencing factors,
and needs an adequate medical infrastructure to avoid negative
long-term outcomes. After their objectification, inappropriate
loads should be avoided by early detection and following
interventions. In synopsis of the results, the occurrence of
clinical symptoms cannot be established by training loads
alone. Furthermore, EBV serostatus and the level of EBV-
specific antibodies do not allow risk stratification for infections.
Further investigations are needed, in particular subgroup-
analyzes of athletes at risk and the addition, respectively
the consideration, of other parameters (e.g., viral load, EBV-
specific T-cell responses, performance data, CRP, leucocytes,
psychological parameters). One strength of our study was that
numerous parameters, in an interdisciplinary approach, were
determined to characterize the collective of adolescent athletes
compared to controls. In contrast to previous studies, upper
respiratory tract infection symptoms were interrogated with a
validated questionnaire (WURSS-21). In further analyzes other
blood parameters for infection detection will be used. Otherwise,
results of susceptibility to infections, training loads, and stress
levels based on self-reported assessments. To our knowledge,
we present the first prospective, controlled study of elite young
athletes to examine the relationship between training load, stress
parameters, immune status and clinical outcomes on such a
large-scale cohort.
AUTHOR CONTRIBUTIONS
KB and BW conceived of the presented idea. KB and BW
developed the theory and performed the computations. KB and
BW verified the analytical methods. All authors discussed the
results and contributed to the final manuscript.
REFERENCES
Alonso, J. M., Tscholl, P., Engebretsen, L., Mountjoy, M., Dvorak, J., and
Junge, A. (2010). Occurrence of injuries and illness during the 2009
IAAF World Athletics Championships. Br. J. Sports Med. 44, 1100–1105.
doi: 10.1136/bjsm.2010.078030
Armstrong, N., andMcManus, A.M. (2011). Preface. The elite young athlete.Med.
Sport Sci. 56, 1–3.
Bakker, N. A., Verschuuren, E. A., and Erasmus, M. E. (2007). Epstein-Barr virus-
DNA load monitoring late after lung transplantation: a surrogate marker of the
degree of immunosuppression and a safe guide to reduce immunosuppression.
Transplantation 83, 433–438. doi: 10.1097/01.tp.0000252784.601
59.96
Balfour, H. H., Dunmire, S. K., and Hogquist, K. A. (2015). Infectious
mononucleosis. Clin. Transl. Immunol. 4:e33. doi: 10.1038/cti.
2015.1
Barrett, B., Brown, R., Mundt, M., Safdar, N., Dye, L., Maberry, R., et al.
(2005). The wisconsin upper respiratory symptom survey is responsive,
reliable, and valid. J. Clin. Epidemiol. 58, 609–617. doi: 10.1016/j.jclinepi.2004.
11.019
Frontiers in Physiology | www.frontiersin.org 12 March 2018 | Volume 9 | Article 120
Blume et al. Immune Status in Young Athletes
Barynina, I. I., and Vaitsekhovskii, S. M. (1992). The aftermath of early sports
specialization for highly qualified swimmers. Fitness Sports Rev. Int. 27,
132–133.
Bompa, T., (1995). From Childhood to Champion Athlete. Toronto, ON: Veritas
Publishing Inc.
Borresen, J., and Lambert, M. I. (2009). The quantification of training load, the
training response and the effect on performance. Sports Med. 39, 779–95.
doi: 10.2165/11317780-000000000-00000
Caine, D. J. (2010). Are kids having a rough time of it in sports? Br. J. Sports Med.
44, 1–3. doi: 10.1136/bjsm.2009.069484
Calder, P. C., and Yaqoob, P., (eds.). (2014). Diet, Immunity and Inflammation.
Cambridge: Woodhead Publishing.
Chieffi, S., Messina, G., and Villano, I. (2017). Neuroprotective effects of physical
activity: evidence from human and animal studies. Front. Neurol. 8:188.
doi: 10.3389/fneur.2017.00188
Cohen, S., Doyle, W. J., Alper, C. M., Janicki-Deverts, D., and Turner, R. B. (2009).
Sleep habits and susceptibility to the common cold. Arch. Intern. Med. 169,
62–67. doi: 10.1001/archinternmed.2008.505
Cohn, P. J. (1990). An exploratory study in sources of stress and athlete burnout in
youth golf. Sport Psychol. 4, 95–106. doi: 10.1123/tsp.4.2.95
Cox, A. J., Gleeson, M., Pyne, D. B., Callister, R., Hopkins, W. G.,
and Fricker, P. A. (2008). Clinical and laboratory evaluation of upper
respiratory symptoms in elite athletes. Clin. J. Sports Med. 18, 438–445.
doi: 10.1097/JSM.0b013e318181e501
Cox, A. J., Gleeson, M., Pyne, D. B., Callister, R., Scott, R., Fricker, P. A., et al.
(2010). Cytokine gene polymorphisms and risk of upper respiratory symptoms
in highly-trained athletes. Exerc. Immunol. Rev. 16, 8–21.
De Paschale, M., and Clerici, P. (2012). Serological diagnosis of Epstein-
Barr virus infection: problems and solutions. World J. Virol. 1, 31–43.
doi: 10.5501/wjv.v1.i1.31
Dennis, R. J., Finch, C. F., and Farhart, J. P. (2005). Is bowling workload a risk
factor for injury to Australian junior cricket fast bowlers? Br. J. Sports Med. 39,
843–846. doi: 10.1136/bjsm.2005.018515
Dhabhar, F. S. (2014). Effects of stress on immune function: the good, the
bad, and the beautiful. Immunol. Res. 58, 193–210. doi: 10.1007/s12026-014-
8517-0
DiFiori, J. P., and Mandelbaum, B. R. (1996). Wrist pain in a young gymnast:
unusual radiographic findings and MRI evidence of growth plate injury.
Med. Sci. Sports Exerc. 28, 1453–1458. doi: 10.1097/00005768-199612000-
00002
Dun, S., Loftice, J., Fleisig, G. S., Kingsley, D., and Andrews, J. R. (2005).
A biomechanical comparison of youth baseball pitches: is the curveball
potentially harmful? Am. J. Sports Med. 36, 686–692. doi: 10.1177/03635465073
10074
Dvorak, J., Junge, A., Derman, W., and Schwellnus, M. (2011). Injuries and
illnesses of football players during the 2010 FIFAWorld Cup. Br. J. Sports Med.
45, 626–630. doi: 10.1136/bjsm.2010.079905
Engebretsen, L., Steffen, K., Alonso, J. M., Aubry, M., Dvorak, J., Junge, A., et al.
(2010). Sports injuries and illnesses during the Winter Olympic Games 2010.
Br. J. Sports Med. 44, 772–780. doi: 10.1136/bjsm.2010.076992
Engebretsen, L., Soligard, T., Steffen, K., Alonsos, J. M., Aubry, M., Budgett, R.,
et al. (2013). Sports injuries and illnesses during the London Summer Olympic
Games 2012. Br. J. Sports Med. 47, 407–411. doi: 10.1136/bjsports-2013-
092380
Fahlman, M. M., and Engels, H. J. (2005). Mucosal IgA and URTI in American
college football players: a year longitudinal study. Med. Sci. Sports Exerc. 37,
374–380. doi: 10.1249/01.MSS.0000155432.67020.88
Fleisig, G. S.,Andrews, J. R.,Cutter, G. R.,Weber, A.,Loftice, J.,McMichael, C.,
et al. (2011). Risk of serious injury for young baseball pitchers: a 10-year
prospective study. Am. J. Sports Med. 39, 253–257. doi: 10.1177/03635465103
84224
Fricker, P. A., McDonald, W. A., Gleeson, M., and Clancy, R. L. (1999).
Exercise-induced hypogammaglobulinemia. Clin. J. Sports Med. 9, 46–49.
doi: 10.1097/00042752-199901000-00009
Fricker, P. A., Gleeson, M., Flanagan, A., Pyne, D. B., McDonald, W. A., and
Clancy, R. L. (2000). A clinical snapshot: do elite swimmers experience
more upper respiratory illness than nonathletes? Clin. Exerc. Physiol. 2,
155–158.
Fricker, P. A., Pyne, D. B., Saunders, P. U., Cox, A. J., Gleeson, M., and
Telford, R. D. (2005). Influence of training loads on runners on patterns
of illness in elite distance runners. Clin. J. Sport Med. 14, 244–250.
doi: 10.1097/01.jsm.0000168075.66874.3e
Fricker, P. A. (1997). “Infectious problems in athletes: an overview,” in Medical
Problems in Athletes, eds K. B. Fields, P. A. Fricker (Malden, MA: Blackwell
Sciences), 3–5.
Gleeson, M. (2000). Mucosal immune responses and risk of respiratory illness in
elite athletes. Exerc. Immunol. Rev. 6, 5–42.
Gleeson, M., and Pyne, D. B. (2016). Respiratory inflammation and
infections in high-performance athletes. Immunol. Cell Biol. 94, 124–131.
doi: 10.1038/icb.2015.100
Gleeson, M., McDonald, W. A., Cripps, A. W., Pyne, D. B., Clancy, R.
L., Fricker, P. A., et al. (1995). The effect on immunity of long-term
intensive training in elite swimmers. Clin. Exp. Immunol. 102, 210–216.
doi: 10.1111/j.1365-2249.1995.tb06658.x
Gleeson, M., Hall, S. T., McDonald,W. A., Flanagan, A. J., and Clancy, R. L. (1999).
Salivary IgA subclasses and infection risk in elite swimmers. Immunol. Cell Biol.
77, 351–355. doi: 10.1046/j.1440-1711.1999.00839.x
Gleeson, M., Ginn, E., and Francis, J. L. (2000). Salivary immunoglobulin
monitoring in an elite kayaker. Clin. J. Sports Med. 10, 206–208.
doi: 10.1097/00042752-200007000-00011
Gleeson, M., Pyne, D. B., Austin, J. P., Lynn Francis, J., Clancy, R. L.,
McDonald, W. A., et al. (2002). Epstein-Barr virus reactivation and upper-
respiratory illness in elite swimmers. Med. Sci. Sports Exerc. 34, 411–417.
doi: 10.1097/00005768-200203000-00005
Gould, D., Jackson, S., and Finch, L. (1993). Sources of stress in national champion
figure skaters. J. Sport Exerc. Psychol. 15, 134–159. doi: 10.1123/jsep.15.
2.134
Hastmann-Walsh, T., and Caine, D. J. (2015). “Injury risk and ist long-term effects
for youth,” in Health and Elite Sports: Is High Performance Sport a Healthy
Pursuit? eds J. Baker, P. Safai, and J. Fraser-Thomas (NewYork, NY: Routledge),
65–80.
He, C. S., Handzlik, M., Muhamad, A., and Gleeson, M. (2013). Influence of
CMV/EBV serostatus on respiratory infection incidence during 4 months of
winter training in a student cohort of endurance athletes. Eur. J. Appl. Physiol.
113, 2613–2619. doi: 10.1007/s00421-013-2704-x
He, C. S., Bishop, N. C., Handzlick, M. K., Muhamad, A. S., and Gleeson, M.
(2014). Sex differences in upper respiratory symptoms prevalence and oral-
respiratory mucosal immunity in endurance athletes. Exerc. Immunol. Rev. 20,
8–22.
Helenius, I., Lumme, A., and Asthma Haahtela, T. (2005). Asthma, airways
inflammation and treatment in elite athletes. Sports Med. 35, 565–572.
doi: 10.2165/00007256-200535070-00002
Hellard, P., Avalos, M., Guimaraes, F., Touissant, J.P., and Pyne, D. B. (2015).
Training-related risk of common illnesses in elite swimmers over a 4-yr
period. Med. Sci. Sports Exerc. 47, 698–707. doi: 10.1249/MSS.00000000000
00461
Himmelstein, S. A., Robergs, R. A., Koehler, K. M., Lewis, S. L., and Qualls, C. R.
(1998). Vitamin C supplementation and upper respiratory tract infections in
marathon runners. J. Exerc. Physiol. 1:17.
Hjelm, N., Werner, S., and Renstrom, P. (2012). Injury risk factors in junior
tennis players: a prospective 2-year study. Scand. J. Med. Sci. Sports 22, 40–48.
doi: 10.1111/j.1600-0838.2010.01129.x
Hoffmann, D., Wolfarth, B., Hörterer, H. G., Halle, M., Reichhuber, C., Nadas,
K., et al. (2010). Elevated Epstein-Barr virus loads and lower antibody
titers in competitive athletes. J. Med. Virol. 82, 446–451. doi: 10.1002/jmv.
21704
Jayanthi, N., Pinkham, C., Dugas, L., Patrick, B., and Labella, C. (2013). Sports
specialization in young athletes: evidence-based recommendations. Sports
Health 5, 251–257. doi: 10.1177/1941738112464626
Karrer, U., and Nadal, D. (2014). Epstein-Barr-Virus und infektiöse
Mononukleose. Schweiz. Med. Forum 14, 226–232. doi: 10.5167/uzh-
96029
Konig, D., Grathwohl, D., Weinstock, C., Northoff, H., and Berg, A. (2000).
Upper respiratory tract infection in athletes: influence of lifestyle, type of
sport, training effects, and immunostimulant intake. Exerc. Immunol. Rev. 6,
102–120.
Frontiers in Physiology | www.frontiersin.org 13 March 2018 | Volume 9 | Article 120
Blume et al. Immune Status in Young Athletes
Lee, P. H. (2016). Physical activity, sedentary behaviors, and Epstein-
Barr virus antibodies in young adults. Physiol. Behav. 164, 390–394.
doi: 10.1016/j.physbeh.2016.06.026
Loud, K. J., Gordon, C.M.,Micheli, L. J., and Field, A. E. (2005). Correlates of stress
fractures among preadolescent and adolescent girls. Pediatrics 115, e399–e406.
doi: 10.1542/peds.2004-1868
Maffulli, N., Longo, U. G., Gougoulias, N., Loppini, M., and Denaro, V. (2010).
Long-term health outcomes of youth sports injuries. Br. J. Sports Med. 44,
21–25. doi: 10.1136/bjsm.2009.069526
Main, L. C., Landers, G. J., Grove, J. R., Dawson, B., and Goodman, C. (2010).
Training patterns and negative health outcomes in triathlon: longitudinal
observations across a full competitive season. J. Sports Med. Phys. Fit. 50,
475–485.
Mårtensson, S., Nordebro, K., and Malm, C. (2014). High training volumes are
associated with a low number of self-reported sick days in elite endurance
athletes. J. Sports Sci. Med. 13, 929–933.
Matthews, C. E., Ockene, I. S., Freedson, P. S., Rosal, M. C., Merrim, P. A.,
and Herbert, J. R. (2002). Moderate to vigorous physical activity and risk
of upper-respiratory tract infection. Med. Sci. Sports Exerc. 34, 1242–1248.
doi: 10.1097/00005768-200208000-00003
Mitchell, J. H., and Haskell, W. (2005). Task Force 8: classification of sports. J. Am.
Coll. Cardiol. 45, 1364–1367. doi: 10.1016/j.jacc.2005.02.015
Monto, A. S. (2002). Epidemiology of viral respiratory infections. Am. J. Med. 112,
4s-12s. doi: 10.1016/S0002-9343(01)01058-0
Mountjoy, M., Armstrong, N., and Bizzini, L. (2008). IOC consensus
statement: training the elite child athlete. Br. J. Sports Med. 42, 163–164.
doi: 10.1136/bjsm.2007.044016
Mountjoy, M., Junge, A., Alonso, J. M., Engebretsen, L., Dragan, I., Gerrard, D.,
et al. (2010). Sports injuries and illness in the 2009 FINAWorld Championships
(Aquatic). Br. J. Sports Med. 44, 522–527. doi: 10.1136/bjsm.2010.
071720
Nieman, D. C., Hanson, D. A., Dumke, C. L., Lind, R. H., Schooter, L. R., and
Gross, S. J., (2006). Relationships between salivary IgA secretion and upper
respiratory tract infection following a 160-km race. J. Sports Med. Phys. Fit. 46,
158–162.
Novas, A., Rowbottom, D., and Jenkins, D. (2002). Total daily energy expenditure
and incidence of upper respiratory tract infection symptoms in young females.
Int. J. Sports Med. 23, 465–70. doi: 10.1055/s-2002-35075
Peters, E. M., and Bateman, E. D. (1983). Ultramarathon running and upper
respiratory tract infections. An epidemiological survey. S. Afr. Med. J. 64,
582–584.
Pottgiesser, T., Wolfarth, B., Schumacher, Y. O., and Bauer, G. (2006).
Epstein-Barr virus serostatus: no difference despite aberrant patterns
in athletes and control group. Med. Sci. Sports Exerc. 38, 1782–1791.
doi: 10.1249/01.mss.0000230122.91264.3f
Pottgiesser, T., Schumacher, Y. O., Wolfarth, B., Schmidt-Trucksäss, A., and
Bauer, G. (2012). Longitudinal observation of epstein-barr virus antibodies
in athletes during a competitive season. J. Med. Virol. 84, 1415–1422.
doi: 10.1002/jmv.23253
Puente-Diaz, R., and Anshel, M. H. (2005). Sources of acute stress,
cognitive appraisal, and coping strategies among highly skilled Mexican
and U.S. competitive tennis players. J. Soc. Psychol. 145, 429–446.
doi: 10.3200/SOCP.145.4.429-446
Puffer, J. C., andMcShane, J. M. (1992). Depression and chronic fatigue in athletes.
Clin. Sports Med. 11, 327–338.
Putlur, P., Foster, C., Miskowski, J. A., Kane, M. K., Burton, S. E., Scheett, T. P.,
et al. (2004). Alteration of immune function in women collegiate soccer players
and college students. J. Sports Sci. Med. 3, 234–244.
Pyne, D. B., Hopkins, W. G., Gleeson, M., and Fricker, P. A. (2005).
Characterising the individual performance responses to mild illness in
international swimmers. Br. J. SportsMed. 39, 752–756. doi: 10.1136/bjsm.2004.
017475
Reid, V. L., Gleeson, M., Williams, N., and Clancy, R. L. (2004). Clinical
investigation of athletes with persistent fatigue and/or recurrent infections. Br.
J. Sports Med. 38, 42–45. doi: 10.1136/bjsm.2002.002634
Sabato, T. M., Walch, T. J., and Caine, D. J. (2016). The elite young athlete:
strategies to ensure physical and emotional health. J. Sports Med. 7, 99–113.
doi: 10.2147/OAJSM.S96821
Scanlan, T. K., Stein, G. L., and Ravizza, K. (1991). An in-depth study of former
elite figure skaters: sources of stress. J. Sport Exerc. Psychol. 13, 103–120.
doi: 10.1123/jsep.13.2.103
Schwellnus, M., Derman, W., Lambert, M., Rehead, C., and Page, T. (2011).
Epidemiology of illness during the Super 14 rugby tournament – a prospective
cohort study. Br. J. Sports Med. 45, 310–314. doi: 10.1136/bjsm.2011.0840
38.20
Schwellnus, M., Derman, W., Page, T., Lambert, M., Readhead, C., Roberts, C.,
et al. (2012). Illness during the 2010 super 14 rugby union tournament – a
prospective study involving 22 676 player days. Br. J. Sports Med. 46, 499–504.
doi: 10.1136/bjsports-2012-091046
Schwellnus, M., Soligard, T., Alonso, J. M., Bahr, R., Clarsen, B., Dijkstra, H.
P., et al. (2016a). How much is too much? (Part 2) International Olympic
Committee consensus statement on load in sport and risk of illness. Br. J. Sports
Med. 50, 1043–1052. doi: 10.1136/bjsports-2016-096572
Schwellnus, M., Soligard, T., Alonso, J.-M., Bahr, R., Clarsen, B., Paul Dijkstra,
H., et al. (2016b). How much is too much? (Part 1) International Olympic
Committee consensus statement on load in sport and risk of injury. Br. J. Sports
Med. 50, 1030–1041. doi: 10.1136/bjsports-2016-096581
Shimizu, K., Aizawa, K., Suzuki, N., Masuchi, K., Okada, H., Akimoto,
T., et al. (2011). Influence of weight loss on monocytes and T-cell
populations in male judo athletes. J. Strength Condit. Res. 25, 1943–1950.
doi: 10.1519/JSC.0b013e3181e4f9c6
Soligard, T., Steffen, K., Palmer Green, D., Aubry, M., Grant, M.E., Meewisse,
W., et al. (2014). Sports injuries and illness in the Sochi 2014 Olympic
Winter Games. Br. J. Sports Med. 49, 441–447. doi: 10.1136/bjsports-2014-
094538
Spence, L., Brown, W. J., Pyne, D. B., Nissen, M. D., Sloots, T. P., McCormack,
J. G., et al. (2007). Incidence, etiology, and symptomatology of upper
respiratory illness in elite athletes. Med. Sci. Sports Exerc. 39, 577–586.
doi: 10.1249/mss.0b013e31802e851a
Svendsen, I. S., Taylor, I. M., Tønnessen, E., Bahr, R., and Gleeson, M. (2016).
Training- and competition-related risk factors for respiratory tract and
gastrointestinal infections in elite cross-country skiers. Br. J. Sports Med. 50,
809–15. doi: 10.1136/bjsports-2015-095398
Theron, N., Schwellnus, M., Derman, W., and Dvorak, J. (2013). Illness
and injuries in elite football players – a prospective cohort study during
the FIFA Confederations Cup 2009. Clin. J. Sport Med. 23, 379–383.
doi: 10.1097/JSM.0b013e31828b0a10
Tiollier, E., Gomez-Merino, D., Burnat, P., Jouanin, J.C., Bourrilhon, C., Filaire, E.,
et al. (2005). Intense training: mucosal immunity and incidence of respiratory
infections. Eur. J. Appl. Physiol. 93, 421–428. doi: 10.1007/s00421-004-
1231-1
Tsai, M. L., Chou, K. M., Chang, C. K., and Fang, S. H. (2011). Changes in mucosal
immunity and antioxidation activity in elitemale Taiwanese taekwondo athletes
associated with intensive training and rapid weight loss. Br. J. Sports Med. 45,
729–734. doi: 10.1136/bjsm.2009.062497
Umeda, T., Nakaji, S., Shimoyama, T., Kojima, A., Yamamoto, Y., and Sugawara,
K. (2004). Adverse effects of energy restriction on changes in immunoglobulins
and complements during weight reduction in judo. J Sports Med. Phys. Fit. 44,
328–334.
Walsh, N. P., and Oliver, S. J. (2016). Exercise, immune function and respiratory
infection: an update on the influence of training and environmental stress.
Immunol. Cell Biol. 94, 132–139. doi: 10.1038/icb.2015.99
Walsh, N. P., Gleeson, M., Shephard, R. J., Gleeson, M., Woods, J. A., and Bishop,
N. C. (2011a). Position statement. Part one: immune function and exercise.
Exerc. Immunol. Rev. 17, 6–63.
Walsh, N. P., Gleeson, M., Pyne, D. B., Nieman, D. C., Dhabhar, F. S., Shephard,
R. J., et al. (2011b). Position statement. part two: maintaining immune health.
Exerc. Immunol. Rev. 17, 64–103.
Wartburton, D. E., and Bredin, S. S. (2016). Reflections on physical activity
and health: what should we recommend? Can. J. Cardiol. 32, 495–504.
doi: 10.1016/j.cjca.2016.01.024
Wartburton, D. E. R., and Bredin, S. S. D. (2017). Health benefits of physical
activity: a systematic review of current systematic reviews. Curr. Opin. Cardiol.
32, 541–556. doi: 10.1097/HCO.0000000000000437
Whittaker, J. L., Woodhouse, L. J., Nettel-Aguirre, A., and Emery, C. A.
(2015). Outcomes associated with early post-traumatic osteoarthritis and
Frontiers in Physiology | www.frontiersin.org 14 March 2018 | Volume 9 | Article 120
Blume et al. Immune Status in Young Athletes
other negative health consequences 3-10 years following knee joint injury
in youth sport. Osteoarthr. Cartil. 23, 1122–1129. doi: 10.1016/j.joca.2015.
02.021
Yamauchi, R., Shimizu, K., Kimura, F., Takemura, M., Suzuki, K., Akama, T.,
et al. (2011). Virus activation and immune function during intense training in
rugby football players. Int. J. Sports Med. 32, 393–398. doi: 10.1055/s-0031-12
71674
Zapico, A. G.,Calderón, F. J., Benito, P. J.,González, C. B.,Parisi, A.,Pigozzi, F., et al.
(2007). Evolution of physiological and hematological parameters with training
load in elite Male road cyclists: a longitudinal study. J. Sports Med. Phys. Fit. 47,
191–196.
Zehsaz, F., Farhangi, N., Monfaredan, A., and Tabatabaei Seyed, M. (2014). IL-
10 G-1082A gene polymorphism and susceptibility to upper respiratory tract
infection among endurance athletes. J. Sports Med. Phys. Fitness 55, 128–134.
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
The handling Editor declared a shared affiliation, though no other collaboration,
with one of the authors KB and BW.
Copyright © 2018 Blume, Körber, Hoffmann and Wolfarth. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) and the copyright owner are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Physiology | www.frontiersin.org 15 March 2018 | Volume 9 | Article 120
